Thierry Boon
Impact in
- Immunology top 0.01%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 0.1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 224
- Immunotherapy and Immune Responses 212
- T-cell and B-cell Immunology 99
- Immune Cell Function and Interaction 69
- Oncology 60
- CAR-T cell therapy research 35
- Cancer Immunotherapy and Biomarkers 22
- Co-authors
- Pierre van der Bruggen (69 shared papers)Pierre G. Coulie (64 shared papers)Etienne De Plaen (58 shared papers)Benoı̂t J. Van den Eynde (38 shared papers)Aline Van Pel (64 shared papers)Christophe Lurquin (38 shared papers)Benoı̂t Van den Eynde (15 shared papers)Bernard Lethé (32 shared papers)
- Journals
- International Journal of Cancer (35 papers)European Journal of Immunology (24 papers)The Journal of Experimental Medicine (22 papers)The Journal of Immunology (17 papers)Proceedings of the National Academy of Sciences (15 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Thierry Boon
263 papers receiving 34.5k citations
Thierry Boon's Hit Papers
Peers
Comparison fields: 5 of 143
- Immunology 27.4k
- Oncology 11.9k
- Biological Psychiatry 976
- Molecular Biology 15.3k
- Radiology, Nuclear Medicine and Imaging 2.9k
Countries citing papers authored by Thierry Boon
This map shows the geographic impact of Thierry Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Boon more than expected).
Fields of papers citing papers by Thierry Boon
This network shows the impact of papers produced by Thierry Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Boon. The network helps show where Thierry Boon may publish in the future.
Co-authors
The 25 scholars most cited alongside Thierry Boon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 267 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma Hit paper breakdown → | 1991 | 2974 |
| 2 | Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Hit paper breakdown → | 2003 | 1949 |
| 3 | Tumor Antigens Recognized by T Lymphocytes Hit paper breakdown → | 1994 | 1066 |
| 4 | Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy Hit paper breakdown → | 2014 | 944 |
| 5 | The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. Hit paper breakdown → | 1993 | 835 |
| 6 | A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. Hit paper breakdown → | 1994 | 822 |
| 7 | Human tumor antigens recognized by T lymphocytes. Hit paper breakdown → | 1996 | 738 |
| 8 | 1997 | 688 | |
| 9 | 1999 | 688 | |
| 10 | 1994 | 682 | |
| 11 | 1992 | 578 | |
| 12 | 2005 | 551 | |
| 13 | 1994 | 533 | |
| 14 | 1995 | 516 | |
| 15 | 1999 | 515 | |
| 16 | 1995 | 509 | |
| 17 | A limiting dilution assay for quantifying Leishmania major in tissues of infected mice Hit paper breakdown → | 1985 | 476 |
| 18 | 1997 | 470 | |
| 19 | 1996 | 459 | |
| 20 | An overview of the MAGE gene family with the identification of all human members of the family. | 2001 | 424 |
About Thierry Boon
Thierry Boon is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 267 papers that have together received 35.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (212 papers), T-cell and B-cell Immunology (99 papers), vaccines and immunoinformatics approaches (83 papers), Immune Cell Function and Interaction (69 papers), Monoclonal and Polyclonal Antibodies Research (42 papers), CAR-T cell therapy research (35 papers), RNA Interference and Gene Delivery (31 papers) and Cancer Immunotherapy and Biomarkers (22 papers). The work is most often cited by research in Immunology (27.4k citations), Oncology (11.9k citations), Biological Psychiatry (976 citations), Molecular Biology (15.3k citations) and Radiology, Nuclear Medicine and Imaging (2.9k citations). Thierry Boon has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Pierre van der Bruggen, Pierre G. Coulie, Etienne De Plaen, Benoı̂t J. Van den Eynde, Aline Van Pel, Christophe Lurquin, Benoı̂t Van den Eynde, Bernard Lethé, Catia Traversari and Patrick Chomez. Their work appears in journals such as International Journal of Cancer, European Journal of Immunology, The Journal of Experimental Medicine, The Journal of Immunology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.